Palmitamido C7 Phosphoramidite
Palmitamido-C7 CE-Phosphoramidite is a long-chain esterified phosphoramidite monomer used for solid-phase oligonucleotide synthesis. Palmitamido-C7 CE-Phosphoramidite is formed by linking palmitamido to the active end of 2-cyanoethyl phosphoramidite via a C7 alkyl spacer arm. Palmitamido-C7 CE-Phosphoramidite can be used as a building block for nucleic acid chemical modification to synthesize ester-coupled oligonucleotides.
For research use only. We do not sell to patients.
- Formula: C53H82N3O6P
- Molecular Weight:888.21
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- Purity & Documentation
-
Help & FAQs
All DNA/RNA Synthesis Isoforms
More
Biological Activity
Chemical Information
-
Molecular Weight 888.21
-
Formula C53H82N3O6P
-
SMILES
CC(C)N(C(C)C)P(OCC(COC(C1=CC=C(C=C1)OC)(C2=CC=CC=C2)C3=CC=C(C=C3)OC)CCCCNC(CCCCCCCCCCCCCCC)=O)OCCC#N
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Palmitamido C7 Phosphoramidite Related Classifications
HY-185910 Related Classifications
Powered by Bioz
- Palmitamido C7 Phosphoramidite
- Phosphoramidites
- DNA/RNA Synthesis
- Palmitamido-C7 CE-Phosphoramidite
- C7 spacer phosphoramidite
- lipid-conjugated oligonucleotide synthesis
- solid-phase oligonucleotide synthesis
- 5′-end modification
- internal modification
- ASO/siRNA lipidation
- 2-cyanoethyl phosphoramidite
- DMT-protected
- palmitamido (C16 amide)
- hydrophobic modification
- extrahepatic delivery
- pharmacokinetic extension.
- Inhibitor
- inhibitor
- inhibit